|
| Human IL-20RA Protein (LTP10388) |
|
| LTP10388 |
|
| 100ug |
|
|
$360 In stock |
| IL-20RA was highly expressed in the tumor tissue of CRC and related to the advanced stage.IL-20RA was involved in regulating oncogenic and immune pathways and affecting the expression of genes related to cell proliferation and immune evasion in CRC.Super-enhancer inhibition by JQ-1 or iBET-151 suppressed the growth of tumor cells and inhibited the expression of IL-20RA. |
| Recombinant Human IL-20RA Protein is expressed from Expi293 with hFc tag at the C-terminal. It contains Val30-Lys250. |
|
| IL-20RA |
|
| Human |
|
| Q9UHF4-1 |
|
| Val30-Lys250 |
|
| The protein has a predicted MW of 52 kDa. Due to glycosylation, the protein migrates to 65-70 kDa based on the Tris-Bis PAGE result. |
|
| 0 |
|
| C-hFc |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
